Dupilumab for Eosinophilic Esophagitis in Patients 1 to 11 Years of Age
N Engl J Med. 2024 Jun 27;390(24):2239-2251. doi: 10.1056/NEJMoa2312282. ABSTRACT BACKGROUND: Dupilumab is a human monoclonal antibody that blocks interleukin-4 and interleukin-13 pathways and has …